HOME >> MEDICINE >> NEWS
Fever of unknown origin: a marker for occult cancer?

EMBARGO: 00:01H (London time) Wednesday September 28, 2005. In North America the embargo lifts at 6:30pm ET Tuesday September 27, 2005. FEVER OF UNKNOWN ORIGIN: A MARKER FOR OCCULT CANCER? Fever of unknown origin might be a marker of occult cancer, according to research published online today by THE LANCET ONCOLOGY.

Fever of unknown origin is characterised by a fever of more than 3 weeks duration, temperatures of more than 38.3C and a failure to identify the origin of the fever. Underlying causes of these fevers are difficult to diagnose, but proposed causes are infections, cancers and collagen-vascular diseases. Henrik Toft Sorensen and colleagues hypothesised that patients with fever of unknown origin might have a higher risk of cancer than the general population.

To test their theory, they assessed 43 205 patients discharged for the first time from Danish hospitals after treatment for fever of unknown origin from 1977-98. Using registry data, they examined whether these patients had a higher risk of subsequent cancer than that expected based on cancer incidence in the general population. They also compared survival of these patients with cancer patients without fever, but matched for cancer site, age at diagnosis of cancer and year of cancer diagnosis.

Within the first year of follow-up after discharge from hospital, patients with fever had an increased risk of developing cancer and 399 cancers were diagnosed (standardised incidence ratio 2.3 [95%CI 2.1-2.5]). This risk was highest for haematological cancers and sarcomas and, although reduced, the overall increased risk remained after 1 year of follow-up. Some cancer patients with fever also had a worse prognosis than did the controls without fever (mortality ratio 1.4 [1.2-1.6]).

Prof Sorensen states "Heightened diagnostic effort could account for some of the association; however, after several years of follow-up, diagnostic bias should not be a major contributing
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
+1-212-633-3810
Lancet
27-Sep-2005


Page: 1 2

Related medicine news :

1. Yellow Fever
2. Benefits of testosterone treatment unknown, research shows
3. The unknown risks of arthritis
4. Daycare illness guidelines exist, but largely unknown
5. Depression linked to previously unknown dopamine regulator
6. Novel candidate biomarker for heart failure also strongly predicts risk of death
7. USC researchers show that molecular markers predict tumor recurrence
8. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
9. Advances in screening and markers improve early detection of colorectal cancer
10. Genetic marker linked to aggressive prostate cancer
11. Genetic markers in surrounding tissues linked to breast cancer tumor grade, presence of metastases

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fever unknown origin marker for occult cancer

(Date:7/24/2014)... 2014 A few weeks have passed ... incredible high jump by Inika McPherson is a feat ... the USATF National Championships hosted the best track and ... McPherson, won US Nationals with the 2nd best jump ... for the biggest height over head jump in history. ...
(Date:7/24/2014)... 2014 Voted one of the most ... clients, BellasDress focuses on providing its new and old ... Recently, the company has announced its new collection of ... range is created according to the latest fashion trends. ... to 68% off. , As a matter of fact, ...
(Date:7/24/2014)... July 24, 2014 The federal ... ) in the U.S. District Court, District ... for plaintiff medical information covered by the federal ... the July 16th Order, U.S. District Judge Douglas ... Fresenius Medical Care the right to receive HIPAA- ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 CarePoint ... specialist in hematology and oncology, Dr. Hitendra Upadhyaya, ... Our system welcomes Dr. Upadhyaya to the community. ... CarePoint Health Medical Group, a comprehensive network of ... a wide range of specialties. This latest acquisition ...
(Date:7/24/2014)... BUFFALO, N.Y. Primary care treatment of overweight and ... and child compared to when only the child is ... Pediatrics and conducted at the University at Buffalo ... in this study were overweight or obese and had ... was overweight or obese, according to body mass index ...
Breaking Medicine News(10 mins):Health News:Setting A New High Jump World Record In Zensah® Compression 2Health News:Setting A New High Jump World Record In Zensah® Compression 3Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Dr. Upadhyaya Joins CarePoint Health Medical Group 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 3
(Date:7/24/2014)... , July 24, 2014  Alimera Sciences, Inc. ... that specializes in the research, development and commercialization of ... its second quarter of fiscal year 2014 financial results ... An investor conference call will follow on the same ... conference call will be hosted by Dan Myers ...
(Date:7/24/2014)... -- Talyst, a market leader in pharmacy automation, will ... Veterans Homes (NASVH) Summer Conference in Charleston, ... is to ensure that each and every eligible US ... and respect which they have earned by their service ... Dispensing System, Talyst can help State Veterans Homes increase ...
(Date:7/24/2014)... 2014 Consolidated Net Profit increased by 43.65 ...   , India Business grew by 20.87% to Rs. ... 4,886.70 Mn Rest of World (ROW) Business grew by ... by 34.53% to Rs. 977.26 Mn Latin America Business ... Glenmark Pharmaceuticals Limited, the research-led global integrated pharmaceutical company, today ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter 2014 Results 2Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 2Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 3Glenmark's Consolidated Revenue Increases by 20.08% to Rs. 14,869.40 Mn for Q1 FY 14 - 15 4
Cached News: